What treatment should be given for multiple sclerosis at the present time?

被引:1
|
作者
Ramo-Tello, C [1 ]
León-Colombo, T [1 ]
机构
[1] Hosp Princesa, Serv Neurol, E-28006 Madrid, Spain
关键词
corticosteroids; interferons; multiple sclerosis; treatment;
D O I
10.33588/rn.3010.99372
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. This communication aims to describe an approach suitable for the general neurologist or neurologist specialized in treating other disorders, to the current treatment of multiple sclerosis. Development and conclusions. We discuss the treatments for recovery from the symptoms of an acute attack and those which modify the natural course of the illness (reduce the frequency and severity of attacks and/or prevent their progression). The attacks are treated with corticosteroids or ACTH Both treatments have been shown on clinical trials to cause rapid improvement of the acute symptoms of an attack. In the progressive forms, the usefulness of high closes of corticosteroids has not been shown. Nor is there evidence that long term corticosteroid treatment, either daily or monthly, is of use in reducing the number of attacks or progression of the disease, although serious side-effects have been seen. At the moment, the interferons are the most popular treatment for multiple sclerosis. They have been the first drugs to modify the course of the disorder. Finally we describe some of the most generally used treatments and some under investigation, although they ave not widely used since it is still not clear exactly how they affect the course of the disease.
引用
收藏
页码:993 / 995
页数:3
相关论文
共 50 条
  • [1] WHAT TREATMENT SHOULD BE GIVEN FOR AGGRESSIVE LYMPHOMAS
    COIFFIER, B
    LYON MEDICAL, 1981, 246 (20): : 421 - 422
  • [2] Pathogenetic treatment of multiple sclerosis: the present and the future
    Boyko, A. N.
    Stolyarov, I. D.
    Sidorenko, T. V.
    Kulakova, O. V.
    Kolyak, E. V.
    Petrov, A. M.
    Ilves, A. G.
    Nikiforova, I. G.
    Favorova, O. O.
    Gusev, E. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (07) : 90 - +
  • [3] What is New in the Treatment of Multiple Sclerosis?
    Bianca Weinstock-Guttman
    Lawrence D. Jacobs
    Drugs, 2000, 59 : 401 - 410
  • [4] What is new in the treatment of multiple sclerosis?
    Weinstock-Guttman, B
    Jacobs, LD
    DRUGS, 2000, 59 (03) : 401 - 410
  • [5] Treatment time for hemodialysis - What should it be?
    Port, FK
    ASAIO JOURNAL, 1997, 43 (03) : 225 - 227
  • [6] Progressive multiple sclerosis 2 Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
    Feinstein, Anthony
    Freeman, Jenny
    Lo, Albert C.
    LANCET NEUROLOGY, 2015, 14 (02): : 194 - 207
  • [7] What treatment should be given to the cryopreserved ovarian tissue after thawing?
    Callejo, J
    Salvador, C
    Prats, P
    Lailla, JM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04): : 1908 - 1909
  • [8] A milestone in multiple sclerosis treatment: what changed in the landscape of the multiple sclerosis treatment with oral medications
    Ozakbas, S.
    Cinar, B. Piri
    Yorgun, Y. Guven
    Kahraman, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 925 - 925
  • [9] Funding of drug treatment of multiple sclerosis should not be delayed
    Paty, DW
    BRITISH MEDICAL JOURNAL, 1997, 315 (7116): : 1160 - 1161
  • [10] Modern multiple sclerosis treatment - what is approved, what is on the horizon
    Pilz, Georg
    Wipfler, Peter
    Ladurner, Gunther
    Kraus, Joerg
    DRUG DISCOVERY TODAY, 2008, 13 (23-24) : 1013 - 1025